Opinion - We have a shot at ending HIV — don’t let politics get in the way
When the next patient asks me about a game-changing HIV prevention tool, I hope I can say, "It's already here and available ...
The Daily News17h
Galveston National Laboratory finds promise in oral anti-virus drug
Obeldesivir is a relatively new antiviral drug with a broad spectrum of potential uses and also is being tested in clinical ...
Hosted on MSN22h
Biopharmaceutical industry sees mixed performance in 2024: report
Over two-thirds of the top 20 global firms reported a decline in market capitalisation. The biopharmaceutical industry showed ...
devdiscourse3h
WHO and Partners Ramp Up Efforts to Combat Sudan Virus Disease in Uganda, Deploying Vaccine Trials and Treatments
The World Health Organization (WHO) and its partners have significantly intensified their support for Uganda's response to the ongoing outbreak of Sudan virus disease (SVD), a deadly illness in the ...
Is Big Pharma About To Win? Goldman Sachs Weighs In On 340B And Medicaid Shifts
Goldman Sachs analyst Salveen Richter highlights potential benefits for biopharma from 340B reforms, while Medicaid cuts ...
Bankrate on MSN14h
Best value ETFs: Top funds that hold bargain-priced stocks
Value outperformed in 2022, with the Russell 1000 Value index falling about 7.5 percent compared to a more than 29 percent ...
Organ Transplantation Immunosuppressive Drug Market Growth Maintained At 4.6% CAGR To Reach 37.3 Billion USD By 2032
Organ Transplantation Immunosuppressive Drug Market. Global Organ Transplantation Immunosuppressive Drug market presents significant growth opportunities.